Windlas Biotech Limited has informed the Exchange about Copy of Newspaper Publication
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Windlas Biotech Limited has announced a buyback of 4,70,000 (4.7 lakh) fully paid-up equity shares with face value of INR 5 each. The buyback price is INR 1,000 per share, payable in cash on a proportionate basis. This means the company is spending approximately INR 470 crore (4.7 billion) to repurchase its shares from shareholders. The offer opens on April 30, 2026 and closes on May 7, 2026. The company has published the offer opening advertisement in Financial Express (English), Jansatta (Hindi), and Dainik Bhaskar (Hindi - Dehradun edition) as required under SEBI Buy-back Regulations.
The buyback at INR 1,000 per share represents a significant premium to the face value of INR 5, signaling management confidence in the company's intrinsic value. Shareholders who tender shares will receive a cash return, while those who hold may benefit from reduced share supply. The large buyback size (INR 470 crore) demonstrates strong cash reserves.